Heart Failure - Prevention & control
Research News and Information

Saturday, November 21, 2009

Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy.

29 Sep 2009 BACKGROUND: The renin-angiotensin system (RAS) plays a central pathogenic role in the development of hypertension and associated vascular disorders. However, whether the two main classes of agents that blunt RAS activity-angiotensin-converting ... Read more...

Sudden cardiac death in China.

30 Aug 2009 Preliminary data suggest that sudden cardiac death (SCD) occur at a rate of 41.8/100,000 population in China, accounting for over 544,000 deaths annually. While about 70% of SCD are due to underlying coronary artery disease, several specific ... Read more...

Current ESC/ESICM and ACCF/AHA guidelines for the diagnosis and management of acute heart failure in adults--are there differences?

30 Aug 2009 There are many similarities between the recommendations of the European and American societies (i.e., the European Society of Cardiology, the European Society of Intensive Care Medicine, the North American College of Cardiology, and the American ... Read more...

Latest indexed articles for 'Heart Failure - Prevention & control'

These are the very latest articles for this heading:

• Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. 29 Sep 2009
• Sudden cardiac death in China. 30 Aug 2009
• Regulation of cardiac hypertrophy by the formation of G protein-coupled receptor--TRPC channel protein complex. 30 Aug 2009
• Current ESC/ESICM and ACCF/AHA guidelines for the diagnosis and management of acute heart failure in adults--are there differences? 30 Aug 2009
• Omega-3 polyunsaturated fatty acids and cardiovascular diseases. 9 Aug 2009
• Hospitalists and the quality of care in hospitals. 8 Aug 2009
• TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload. 5 Aug 2009
• Long-term clinical outcome and left ventricular lead position in cardiac resynchronization therapy. 4 Aug 2009
• Letter by barrios et Al regarding article, "heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial". 2 Aug 2009
• Impact of preoperative nesiritide on renal function after mitral valve surgery. 30 Jul 2009
• Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapy. 30 Jul 2009
• Intracardiac echocardiography-guided cardiac resynchronization therapy: technique and clinical application. 30 Jul 2009
• Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy. 30 Jul 2009
• In-ambulance abciximab administration in STEMI patients prior to primary PCI is associated with smaller infarct size, improved LV function and lower incidence of heart failure: results from the Leiden MISSION! acute myocardial infarction treatment optimization program. 30 Jul 2009
• Primary percutaneous coronary intervention decision-making becomes more confusing: where do glycoprotein 2b/3a inhibitors "fit" now? 30 Jul 2009
• Do some implant too many defibrillators or others too few? 30 Jul 2009
• Better adherence to antihypertensive agents and risk reduction of chronic heart failure. 30 Jul 2009
• [Cheyne-Stokes respiration and cardiovascular risk] 7 Jul 2009
• Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy. 2 Jul 2009
• Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts. 30 Jun 2009

See a longer list of these articles.

Technical information about 'Heart Failure'

Definition: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.

Descriptor UI: D006333

Alternative terms: Heart Failure; Cardiac Failure; Myocardial Failure; Heart Failure, Left-Sided; Heart Failure, Left Sided; Left-Sided Heart Failure; Left Sided Heart Failure; Heart Failure, Right-Sided; Heart Failure, Right Sided; Right-Sided Heart Failure; Right Sided Heart Failure; Congestive Heart Failure; Heart Failure, Congestive; Heart Decompensation; Decompensation, Heart;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C14.280.434;

History Note: 2008 (1966)

Technical Notes: "scompenso di cuore" is "heart decompensation" in Italian; do not confuse with CARDIOMYOPATHY, CONGESTIVE